조성엽 (서울대학교 의과대학)님 | 한빛사연구자 > 한빛사

서울대학교 의과대학

CV File

종양의학

최종업데이트 2026.08.03.

KRAS Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer
- Cancer Res., Jul 29 2026, | https://doi.org/10.1158/0008-5472.CAN-26-0403
- 2026-07
- 의약학
- 한빛사논문
Differential DNA damage response to WRN inhibition identifies a targetable vulnerability in ARID1A-mutated cancers
- Sci. Adv., Jun 05 2026, 12 (23) eaeb3726 | https://doi.org/10.1126/sciadv.aeb3726
- 2026-06
- 의약학
- 한빛사논문
Therapeutic Potential of HSP90 Inhibitor 17-DMAG in Regulating METTL3 for Kidney Fibrosis Treatment
- J. Am. Soc. Nephrol., Jan 26 2026, | https://doi.org/10.1681/ASN.0000000975
- 2026-01
- 의약학
- 한빛사논문
Comprehensive profiling of RNA modification-related genes identifies RNA m7G binding protein CBP20 as a therapeutic target for tumor growth inhibition
- Exp. Mol. Med., Sep 01 2025, | https://doi.org/10.1038/s12276-025-01531-z
- 2025-09
- 의약학
- 한빛사논문
Tumor-promoting UBR4 coordinates impaired mitophagy-associated senescence and lung adenocarcinoma pathogenesis
- Proc. Natl. Acad. Sci. USA, Jun 24 2025, 122 (25) | https://doi.org/10.1073/pnas.2425015122
- 2025-06
- 생명과학
- 한빛사논문
RNA N6-Methyladenosine-Binding Protein YTHDFs Redundantly Attenuate Cancer Immunity by Downregulating IFN-γ Signaling in Gastric Cancer
- Adv. Sci., Nov 25 2024, | https://doi.org/10.1002/advs.202410806
- 2024-11
- 의약학
- 한빛사논문
Genome-wide CRISPR screening identifies tyrosylprotein sulfotransferase-2 as a target for augmenting anti-PD1 efficacy
- Mol. Cancer, Aug 02 2024, 23 (1) 155 | https://doi.org/10.1186/s12943-024-02068-x
- 2024-08
- 의약학
- 한빛사논문
Comprehensive molecular characterization of TFE3-rearranged renal cell carcinoma
- Exp. Mol. Med., 01 August 2024 | https://doi.org/10.1038/s12276-024-01291-2
- 2024-08
- 한빛사논문
Targeting the m6A RNA methyltransferase METTL3 attenuates the development of kidney fibrosis
- Exp. Mol. Med., 01 February 2024 | https://doi.org/10.1038/s12276-024-01159-5
- 2024-02
- 한빛사논문
Augmentation of the RNA m6A reader signature is associated with poor survival by enhancing cell proliferation and EMT across cancer types
- Exp. Mol. Med., Published 06 July 2022 | https://doi.org/10.1038/s12276-022-00795-z
- 2022-07
- 의약학
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기